However, given the small sample size and the extreme heterogeneity of the control group, it could be useful in future studies to increase the sample and make a comparison between salivary levels of lactoferrin in AD patients and—separately—with other neurodegenerative diseases (e.g., AD vs. FTD vs. VaD vs. DLB vs. PDD). Here, LTF is linked to Alzheimer disease.